Old Web
English
Sign In
Acemap
>
authorDetail
>
Monique S Tomiczek
Monique S Tomiczek
Hoffmann-La Roche
Obinutuzumab
Medicine
Internal medicine
Follicular lymphoma
Oncology
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OBINUTUZUMAB CAN BE ADMINISTERED AS A 90‐MINUTE SHORT‐DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: GAZELLE END OF INDUCTION ANALYSIS
2021
Hematological Oncology
K Hübel
Thomas A. Buchholz
Koji Izutsu
Takayuki Ishikawa
Laura Fogliatto
E. Vorozheikina
D. Klingbiel
S. Pokala
Monique S Tomiczek
Joana Parreira
Miguel Canales
Show All
Source
Cite
Save
Citations (0)
Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.
2021
Journal of Clinical Oncology
Miguel Ángel Canales Albendea
Thomas A. Buchholz
Koji Izutsu
Takayuki Ishikawa
Laura Fogliatto
Ekaterina Vorozheikina
D. Klingbiel
Sunny Pokala
Monique S Tomiczek
Joana Parreira
Kai Hübel
Show All
Source
Cite
Save
Citations (0)
Primary Analysis of the Tegar Study: A Phase II Study Exploring the Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab or Rituximab in Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), or Waldenstrom Macroglobulinemia (WM)
2020
Blood
Panayiotis Panayiotidis
Gayane Tumyan
Catherine Thieblemont
Vadim V. Ptushkin
Ana Marín Niebla
Ramón García-Sanz
Andrey Zaritskey
Steven Le Gouill
Christian Buske
Marlies E.H.M. Van Hoef
Thomas Perretti
Monique S Tomiczek
Anastasios Stathis
Show All
Source
Cite
Save
Citations (1)
Ongoing Study of Obinutuzumab Short Duration Infusion in Patients with Previously Untreated Advanced Follicular Lymphoma
2019
Blood
Miguel Canales
Thomas A. Buchholz
James Mason
Joana M Parreira
Monique S Tomiczek
Kai Hübel
Show All
Source
Cite
Save
Citations (0)
1